ADAMIS PHARMACEUTICALS CORP's ticker is ADMP and the CUSIP is 00547W208. A total of 50 filers reported holding ADAMIS PHARMACEUTICALS CORP in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $2,550 | -31.5% | 22,000 | 0.0% | 0.00% | – |
Q4 2022 | $3,725 | -6.9% | 22,000 | 0.0% | 0.00% | -100.0% |
Q3 2022 | $4,000 | -63.6% | 22,000 | 0.0% | 0.00% | 0.0% |
Q2 2022 | $11,000 | -15.4% | 22,000 | 0.0% | 0.00% | 0.0% |
Q1 2022 | $13,000 | 0.0% | 22,000 | 0.0% | 0.00% | 0.0% |
Q4 2021 | $13,000 | -38.1% | 22,000 | 0.0% | 0.00% | -66.7% |
Q3 2021 | $21,000 | -53.3% | 22,000 | -50.0% | 0.00% | 0.0% |
Q2 2021 | $45,000 | +114.3% | 44,000 | +100.0% | 0.00% | 0.0% |
Q1 2021 | $21,000 | +90.9% | 22,000 | 0.0% | 0.00% | +50.0% |
Q4 2020 | $11,000 | -35.3% | 22,000 | 0.0% | 0.00% | -33.3% |
Q3 2020 | $17,000 | +41.7% | 22,000 | 0.0% | 0.00% | +50.0% |
Q2 2020 | $12,000 | +50.0% | 22,000 | 0.0% | 0.00% | 0.0% |
Q1 2020 | $8,000 | -46.7% | 22,000 | 0.0% | 0.00% | 0.0% |
Q4 2019 | $15,000 | -54.5% | 22,000 | -53.2% | 0.00% | -66.7% |
Q3 2019 | $33,000 | -45.9% | 47,000 | 0.0% | 0.01% | -45.5% |
Q2 2019 | $61,000 | -38.4% | 47,000 | 0.0% | 0.01% | -38.9% |
Q1 2019 | $99,000 | -6.6% | 47,000 | 0.0% | 0.02% | -28.0% |
Q4 2018 | $106,000 | -7.0% | 47,000 | +44.6% | 0.02% | +8.7% |
Q3 2018 | $114,000 | +9.6% | 32,500 | 0.0% | 0.02% | 0.0% |
Q2 2018 | $104,000 | -8.8% | 32,500 | 0.0% | 0.02% | -11.5% |
Q1 2018 | $114,000 | -20.3% | 32,500 | 0.0% | 0.03% | -21.2% |
Q4 2017 | $143,000 | -15.9% | 32,500 | 0.0% | 0.03% | -21.4% |
Q3 2017 | $170,000 | +18.9% | 32,500 | +18.2% | 0.04% | +10.5% |
Q2 2017 | $143,000 | +49.0% | 27,500 | +22.2% | 0.04% | +46.2% |
Q1 2017 | $96,000 | +95.9% | 22,500 | +45.2% | 0.03% | +73.3% |
Q4 2016 | $49,000 | – | 15,500 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|